MUC1 and breast cancer

被引：0
|
作者：
Apostolopoulos, V [1 ]
Pietersz, GA [1 ]
McKenzie, IFC [1 ]
机构：
[1] Austin & Repatriat Med Ctr, Austin Res Inst, Heidelberg, Vic 3084, Australia
来源：
CURRENT OPINION IN MOLECULAR THERAPEUTICS | 1999年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The development of an effective immunotherapeutic approach to cancer is now a major focus of research, and despite impressive progress over the last 10 years there are still many hurdles to overcome to elicit an effective immune response which will totally eradicate the cancer. Mucins (MUC1) have attracted interest as potential targets for immunotherapy of cancers of breast, pancreas, ovary and others, and we have demonstrated that mannan, a polymannose carbohydrate is an effective carrier for MUC1 in eliciting a cellular immune response. Several clinical trials are in progress to evaluate the immunogenicity of MUC1 and its suitability as to use for immunotherapy/vaccine for breast cancer.
引用
收藏
页码：98 / 103
页数：6
相关论文
共 50 条
  • [31] MUC1 in endometriosis and ovarian cancer
    Anda M. Vlad
    Iulia Diaconu
    Kira R. Gantt
    [J]. Immunologic Research, 2006, 36 : 229 - 236
  • [32] Significance of MUC1 in bladder cancer
    Ahmad, Sarfraz
    Lam, Thomas B. L.
    N'Dow, James
    [J]. BJU INTERNATIONAL, 2015, 115 (01) : 161 - 162
  • [33] MUC1 and MUC-X, epithelial mucins of breast and milk
    Patton, S
    [J]. BIOACTIVE COMPONENTS OF HUMAN MILK, 2001, 501 : 35 - 45
  • [34] Expression of MUC1 and MUC2 in Ampullary Cancer
    Moriya, Toshiyuki
    Kimura, Wataru
    Hirai, Ichiro
    Takasu, Naoki
    Mizutani, Masaomi
    [J]. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2011, 19 (04) : 441 - 447
  • [35] Targeting glutamine metabolism in MUC1 expressing triple negative breast cancer
    Goode, Gennifer D.
    Gunda, Venugopal
    Singh, Pankaj
    [J]. CANCER RESEARCH, 2017, 77
  • [36] Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes
    Wilkie, S.
    Brenner, M. K.
    Taylor-Papadimitriou, J.
    Burchell, J.
    Maher, J.
    [J]. BREAST CANCER RESEARCH, 2006, 8 (Suppl 2) : S17 - S18
  • [37] MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
    Aysooda Hosseinzadeh
    Parnaz Merikhian
    Nazanin Naseri
    Mohammad Reza Eisavand
    Leila Farahmand
    [J]. Cancer Cell International, 22
  • [38] MUC1 targeting tissue-specific expression in breast cancer cultures
    Filinova, E.
    Isakov, M.
    Gagarina, E.
    Galkin, A.
    [J]. EJC SUPPLEMENTS, 2008, 6 (09): : 93 - 94
  • [39] MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
    Hosseinzadeh, Aysooda
    Merikhian, Parnaz
    Naseri, Nazanin
    Eisavand, Mohammad Reza
    Farahmand, Leila
    [J]. CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [40] Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1
    Musselli, C
    Ragupathi, G
    Gilewski, T
    Panageas, KS
    Spinat, Y
    Livingston, PO
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) : 660 - 667
12345